1
|
Bampi SR, Casaril AM, Domingues M, de Andrade Lourenço D, Pesarico AP, Vieira B, Begnini KR, Seixas FK, Collares TV, Lenardão EJ, Savegnago L. Depression-like behavior, hyperglycemia, oxidative stress, and neuroinflammation presented in diabetic mice are reversed by the administration of 1-methyl-3-(phenylselanyl)-1H-indole. J Psychiatr Res 2020; 120:91-102. [PMID: 31654972 DOI: 10.1016/j.jpsychires.2019.10.003] [Citation(s) in RCA: 19] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/18/2019] [Revised: 09/24/2019] [Accepted: 10/03/2019] [Indexed: 02/08/2023]
Abstract
Oxidative stress and neuroinflammation are found both in diabetes mellitus and major depressive disorder (MDD). In addition to damage in peripheral organs, such as liver and kidney, diabetic patients have a higher risk of developing depression. In this sense, the objective of the present study was to characterize the antidepressant-like effect of a selenium-containing compound, the 1-methyl-3-(phenylselanyl)-1H-indole (MFSeI), in streptozotocin (STZ)-induced diabetic mice. STZ (200 mg/kg, i.p.) was used to induce diabetes mellitus type I, and after seven days, the administration of MFSeI (10 mg/kg, i.g.) was initiated and followed for the next 14 days. Twenty-four hours after the last administration of MFSeI, the behavioral tests were performed, followed by euthanasia. The treatment with MFSeI was able to reverse the hyperglycemia induced by STZ. MFSeI also decreased the plasma levels of biomarkers of liver and kidney damage. Importantly, MFSeI reversed the depression-like behavior induced by STZ in the tail suspension test and forced swimming test without promoting locomotor alterations. Furthermore, MFSeI reversed the increased levels of reactive species and lipid peroxidation in the prefrontal cortex (PFC), hippocampus (HC), liver, and kidney of STZ-treated mice. Treatment with MFSeI also decreased the expression of tumor necrosis factor-alpha, inducible nitric oxide synthase and indoleamine 2,3-dioxygenase, while increasing the expression of interleukin-10, insulin receptor substrate-1 and glucose transport-4 in the PFC and HC of mice. Taken together, the results indicate the effectiveness of MFSeI against depression-like behavior and central and peripheral complications caused by diabetes in mice.
Collapse
Affiliation(s)
- Suely Ribeiro Bampi
- Neurobiotechnology Research Group, Center of Biotechnology, Federal University of Pelotas, RS, Brazil
| | - Angela Maria Casaril
- Neurobiotechnology Research Group, Center of Biotechnology, Federal University of Pelotas, RS, Brazil
| | - Micaela Domingues
- Neurobiotechnology Research Group, Center of Biotechnology, Federal University of Pelotas, RS, Brazil
| | | | - Ana Paula Pesarico
- Neurobiotechnology Research Group, Center of Biotechnology, Federal University of Pelotas, RS, Brazil
| | - Beatriz Vieira
- Laboratory of Clean Organic Synthesis, Center of Chemical, Pharmaceutical and Food Sciences, Federal University of Pelotas, RS, Brazil
| | - Karine Rech Begnini
- Cellular and Molecular Oncology Research Group, Center of Biotechnology, Federal University of Pelotas, RS, Brazil
| | - Fabiana K Seixas
- Cellular and Molecular Oncology Research Group, Center of Biotechnology, Federal University of Pelotas, RS, Brazil
| | - Tiago Veiras Collares
- Cellular and Molecular Oncology Research Group, Center of Biotechnology, Federal University of Pelotas, RS, Brazil
| | - Eder João Lenardão
- Laboratory of Clean Organic Synthesis, Center of Chemical, Pharmaceutical and Food Sciences, Federal University of Pelotas, RS, Brazil
| | - Lucielli Savegnago
- Neurobiotechnology Research Group, Center of Biotechnology, Federal University of Pelotas, RS, Brazil.
| |
Collapse
|
2
|
Solovyev N, Vanhaecke F, Michalke B. Selenium and iodine in diabetes mellitus with a focus on the interplay and speciation of the elements. J Trace Elem Med Biol 2019; 56:69-80. [PMID: 31442957 DOI: 10.1016/j.jtemb.2019.07.005] [Citation(s) in RCA: 16] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/29/2018] [Revised: 07/07/2019] [Accepted: 07/17/2019] [Indexed: 12/13/2022]
Abstract
Diabetes mellitus is a chronic metabolic disease caused by insulin deficiency (type I) or dysfunction (type II). Diabetes is a threatening public health concern. It is considered as one of the priority non-communicable diseases, due to its high and increasing incidence, the associated healthcare costs, and threatening medical complications. Two trace elements selenium (Se) and iodine (I) were intensively discussed in the context of diabetic pathology and, possibly, etiology. It seems there is a multilayer involvement of these essential nutrients in glucose tolerance, energy metabolism, insulin signaling and resistance, which are mainly related to the antioxidant selenoenzymes and the thyroid hormones. Other factors might be related to (auto)immunity, protection against endoplasmic reticulum stress, and leptin signaling. The aim of the current review is to evaluate the current understanding of the role of selenium and iodine in diabetes with a focus on the biochemical interplay between the elements, their possible role as biomarkers, and their chemical speciation. Possible impacts from novel analytical techniques related to trace element speciation and isotopic analysis are outlined.
Collapse
Affiliation(s)
- Nikolay Solovyev
- St. Petersburg State University, Universitetskaya nab. 7/9, 199034, St. Petersburg, Russian Federation; Ghent University, Department of Chemistry, Atomic & Mass Spectrometry - A&MS Research Unit, Campus Sterre, Krijgslaan 281-S12, 9000, Ghent, Belgium.
| | - Frank Vanhaecke
- Ghent University, Department of Chemistry, Atomic & Mass Spectrometry - A&MS Research Unit, Campus Sterre, Krijgslaan 281-S12, 9000, Ghent, Belgium
| | - Bernhard Michalke
- Helmhotz Zentrum München - German Research Center for Environmental Health, Research Unit Analytical BioGeoChemistry, Ingolstaedter Landstr. 1, 85764, Neuherberg, Germany
| |
Collapse
|
3
|
Moreira LDPD, Gomes JVP, Mattar JB, Chaves LO, Martino HSD. Potential of trace elements as supplements for the metabolic control of Type 2 Diabetes Mellitus: A systematic review. J Funct Foods 2019. [DOI: 10.1016/j.jff.2019.04.015] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/05/2023] Open
|
4
|
Wang N, Tan HY, Li S, Xu Y, Guo W, Feng Y. Supplementation of Micronutrient Selenium in Metabolic Diseases: Its Role as an Antioxidant. OXIDATIVE MEDICINE AND CELLULAR LONGEVITY 2017; 2017:7478523. [PMID: 29441149 PMCID: PMC5758946 DOI: 10.1155/2017/7478523] [Citation(s) in RCA: 146] [Impact Index Per Article: 20.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 06/28/2017] [Revised: 10/28/2017] [Accepted: 11/05/2017] [Indexed: 02/06/2023]
Abstract
Selenium is an essential mineral naturally found in soil, water, and some of the food. As an antioxidant, it is one of the necessary trace elements in human body and has been suggested as a dietary supplement for health benefit. Although the human body only needs a trace amount of selenium every day, plenty of recent studies have revealed that selenium is indispensable for maintaining normal functions of metabolism. In this study, we reviewed the antioxidant role of nutritional supplementation of selenium in the management of major chronic metabolic disorders, including hyperlipidaemia, hyperglycaemia, and hyperphenylalaninemia. Clinical significance of selenium deficiency in chronic metabolic diseases was elaborated, while clinical and experimental observations of dietary supplementation of selenium in treating chronic metabolic diseases, such as diabetes, arteriosclerosis, and phenylketonuria, were summarized. Toxicity and recommended dose of selenium were discussed. The mechanism of action was also proposed via inspecting the interaction of molecular networks and predicting target protein such as xanthine dehydrogenase in various diseases. Future direction in studying the role of selenium in metabolic disorders was also highlighted. In conclusion, highlighting the beneficial role of selenium in this review would advance our knowledge of the dietary management of chronic metabolic diseases.
Collapse
Affiliation(s)
- Ning Wang
- School of Chinese Medicine, The University of Hong Kong, Pokfulam, Hong Kong
| | - Hor-Yue Tan
- School of Chinese Medicine, The University of Hong Kong, Pokfulam, Hong Kong
| | - Sha Li
- School of Chinese Medicine, The University of Hong Kong, Pokfulam, Hong Kong
| | - Yu Xu
- School of Chinese Medicine, The University of Hong Kong, Pokfulam, Hong Kong
| | - Wei Guo
- School of Chinese Medicine, The University of Hong Kong, Pokfulam, Hong Kong
| | - Yibin Feng
- School of Chinese Medicine, The University of Hong Kong, Pokfulam, Hong Kong
| |
Collapse
|
6
|
Abstract
Selenoproteins are proteins containing selenium in the form of the 21st amino acid, selenocysteine. Members of this protein family have many diverse functions, but their synthesis is dependent on a common set of cofactors and on dietary selenium. Although the functions of many selenoproteins are unknown, several disorders involving changes in selenoprotein structure, activity or expression have been reported. Selenium deficiency and mutations or polymorphisms in selenoprotein genes and synthesis cofactors are implicated in a variety of diseases, including muscle and cardiovascular disorders, immune dysfunction, cancer, neurological disorders and endocrine function. Members of this unusual family of proteins have roles in a variety of cell processes and diseases.
Collapse
|
7
|
Bilginoglu A, Seymen A, Tuncay E, Zeydanli E, Aydemir-Koksoy A, Turan B. Antioxidants but not doxycycline treatments restore depressed beta-adrenergic responses of the heart in diabetic rats. Cardiovasc Toxicol 2009; 9:21-9. [PMID: 19294534 DOI: 10.1007/s12012-009-9032-8] [Citation(s) in RCA: 14] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/12/2008] [Accepted: 03/04/2009] [Indexed: 12/28/2022]
Abstract
Reactive oxygen species (ROS) play important roles in the development of diabetic cardiomyopathy. Matrix metalloproteinases (MMPs) can get activated by ROS and contribute to loss of myocardial contractile function in oxidative stress injury. Previously we have shown that either a MMP-2 inhibitor doxycycline or an antioxidant selenium treatment in vivo prevented diabetes-induced cardiac dysfunction significantly. In addition, there is an evidence for impaired cardiac responsiveness to beta-adrenoceptor (beta AR) stimulation in experimental animals with diabetes. The exact nature of linkage between the functional depression in cardiac responses to catecholamines and the variations in uncoupling of beta AR in diabetes has not been clearly defined. Therefore, we aimed to evaluate the effect of in vivo administration of doxycycline on beta AR responses of isolated hearts from diabetic rats and compare these data with two well-known antioxidants; sodium selenate and (n-3) fatty acid-treated diabetic rats. We examined the changes in the basal cardiac function in response to the beta AR stimulation, adenylate cyclase activity, and beta AR affinity to its agonist, isoproterenol. These results showed that antioxidant treatment of diabetic rats could protect the hearts against diabetes-induced depression in beta AR responses, significantly while doxycycline did not have any significant beneficial action on these parameters. As a summary, present data, in part, demonstrate that antioxidants and MMP inhibitors could both regulate MMP function but may also utilize different mechanisms of action in cardiomyocytes, particularly related with beta AR signaling pathway.
Collapse
MESH Headings
- Adenylyl Cyclases/metabolism
- Adrenergic beta-Agonists/pharmacology
- Animals
- Antioxidants/pharmacology
- Cardiomyopathies/etiology
- Cardiomyopathies/metabolism
- Cardiomyopathies/physiopathology
- Cardiomyopathies/prevention & control
- Diabetes Mellitus, Experimental/complications
- Diabetes Mellitus, Experimental/drug therapy
- Diabetes Mellitus, Experimental/metabolism
- Diabetes Mellitus, Experimental/physiopathology
- Dose-Response Relationship, Drug
- Doxycycline/pharmacology
- Fatty Acids, Omega-3/pharmacology
- Isoproterenol/pharmacology
- Male
- Matrix Metalloproteinase 2/metabolism
- Matrix Metalloproteinase Inhibitors
- Myocardium/enzymology
- Myocardium/metabolism
- Protease Inhibitors/pharmacology
- Rats
- Rats, Wistar
- Reactive Oxygen Species/metabolism
- Receptors, Adrenergic, beta/drug effects
- Receptors, Adrenergic, beta/metabolism
- Selenic Acid
- Selenium Compounds/pharmacology
- Ventricular Function, Left/drug effects
- Ventricular Pressure/drug effects
Collapse
Affiliation(s)
- Ayca Bilginoglu
- Department of Biophysics, Faculty of Medicine, Ankara University, Ankara, Turkey
| | | | | | | | | | | |
Collapse
|